The Weekly Litigation News Digest is now live. Subscribe now

Plexxikon competitive analysis

Loading summary...

Explore Plexxikon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jan 10, 2018Propane-I-Sulfonic Acid {3- [5- (4- Chloro-Phenyl) -1H-Pyrrolo [2, 3-B} Pyridine-3-Carbonyl] -2, 4-Difluoro-Phenyl} -Amide Compositions And Uses Thereof1

Latest PTAB cases involving Plexxikon

Discover the latest PTAB cases involving Plexxikon, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Plexxikon

IPR2018-01287Jun 18, 2018NOVARTIS PHARMACEUTICALSPLEXXIKONInstitution Denied
PGR2018-00069Jun 18, 2018NOVARTIS PHARMACEUTICALPLEXXIKONInstitution Denied

Peer Comparison New

IP litigation analysis comparing Plexxikon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PLEXXIKON - 1 - 2
GENERICS UK214 - - -
NOVARTIS PHARMACEUTICAL - - 1 -
NOVARTIS PHARMACEUTICALS - - 45